Streptococcus pneumoniae is one of the leading causes of bacteremia (S. pneumoniae in the blood), bacterial meningitis (infection in the lining around the brain), pneumonia (lung infection), and middle ear infections in infants and young children, and remains a significant cause of disease worldwide.
This research study is to evaluate an investigational vaccine intended to increase protection against infections caused by Streptococcus pneumoniae.
- Must be 42 to 90 days old
- Must NOT have received a non-live vaccine in the past 14 days, or a live vaccine in the past 30 days
- Must NOT have already received a pneumococcal vaccine
- Will receive compensation for study-related time
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for your child.
You can talk to a Meridian enrollment specialist about this study by calling (912) 623-2240 (Macon) or (712) 639-6200 (Hastings or Charleston).
Submit your information
Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.